The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung

Related Experiment Video

Updated: Aug 13, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Mary Beth Beasley1, Sylvie Lantuejoul, Susan Abbondanzo

  • 1Department of Pathology, Tulane University, New Orleans, LA, USA.

Human Pathology
|March 4, 2003
PubMed

Insights

The Rb pathway is compromised in high-grade neuroendocrine lung tumors, mainly due to Rb protein loss. This pathway remains intact in low-grade tumors, suggesting potential therapeutic targets for neuroendocrine lung cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • The Retinoblastoma (Rb) protein is a critical regulator of the G1 cell cycle arrest.
  • Dysregulation of the Rb pathway, through cyclin D1 overexpression or P16(INK4) loss, leads to persistent Rb hyperphosphorylation and cell cycle evasion.
  • Understanding Rb pathway alterations is crucial for neuroendocrine lung tumors (NLТs).

Purpose of the Study:

  • To investigate the mechanisms of Rb protein loss in neuroendocrine lung tumors.
  • To analyze the P16(INK4)/cyclin D1/Rb pathway across the spectrum of neuroendocrine lung tumors.
  • To correlate Rb pathway alterations with tumor grade and patient survival.

Main Methods:

  • Immunohistochemical analysis of the P16(INK4)/cyclin D1/Rb pathway.
  • Study cohort included typical carcinoids (TCs), atypical carcinoids (ACs), large cell neuroendocrine carcinomas (LCNECs), and small cell lung carcinomas (SCLCs).
  • Statistical analysis to determine relationships between pathway components, tumor types, and survival.

Main Results:

  • Rb expression was absent in 21% of ACs, 68% of LCNECs, and 87% of SCLCs, but not in TCs.
  • The Rb pathway was altered in 92% of high-grade neuroendocrine lung tumors, primarily due to Rb loss, and intact in TCs.
  • Rb pathway alterations were more frequent in ACs than TCs (P=0.001) and in LCNECs than ACs (P=0.001).

Conclusions:

  • The Rb pathway is consistently compromised in high-grade neuroendocrine lung tumors, mainly via Rb protein loss.
  • Low-grade TCs maintain an intact Rb pathway.
  • Alterations in the Rb pathway, particularly Rb loss, may offer specific therapeutic targets for neuroendocrine lung tumors.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...